This approval secures market access for dsm-firmenich’s 2’-FL human milk oligosaccharide (HMO) ingredient, commercially known as GLYCARE 2FL 9000 dsm-firmenich, innovators in nutrition, health, and beauty, announced that its Escherichia coli K-12 DH1…

This approval secures market access for dsm-firmenich’s 2’-FL human milk oligosaccharide (HMO) ingredient, commercially known as GLYCARE 2FL 9000

dsm-firmenich, innovators in nutrition, health, and beauty, announced that its Escherichia coli K-12 DH1 MDO strain for 2’-Fucosyllactose (2’-FL) production has received safety clearance from the Indonesian Biosafety Clearing House. This approval secures market access for dsm-firmenich’s 2’-FL human milk oligosaccharide (HMO) ingredient commercially known as GLYCARE 2FL 9000—in flavoured liquid milk drinks for ages three and older.

The commission also found that dsm-firmenich’s 2’-FL ingredient does not show any potential to cause allergies, is classified as a non-toxic substance, and is safe for consumption as a food ingredient.

“This safety clearance is a significant step forward in dsm-firmenich’s mission to improve access to HMOs worldwide, with ingredients from our GLYCARE® HMO portfolio now available for use in more than 165 countries,” comments Elaine Tan, Regulatory Affairs Manager for the Asia-Pacific team at dsm-firmenich.

“Emerging evidence shows a myriad of health benefits provided by HMOs in early life nutrition, through childhood and beyond,” adds Anita Wichmann, Lead Expert in Regulatory Affairs for Early Life Nutrition, Medical Nutrition and HMOs at dsm-firmenich. “The newly secured market access for GLYCARE® 2FL 9000 opens new opportunities for innovators in Indonesia to harness these benefits in nutritional solutions that support the gut health of children and adults.”